Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer

BACKGROUND: Radioimmunotherapy has become one of the most promising strategies for cancer treatment. Preclinical and clinical studies have demonstrated that antiangiogenic therapy can improve the efficacy of immunotherapy and sensitize radiotherapy through a variety of mechanisms. However, it is und...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng, Zhai, Yirui, Men, Yu, Zhao, Maoyuan, Sun, Xin, Ma, Zeliang, Bao, Yongxing, Yang, Xu, Sun, Shuang, Liu, Yunsong, Zhang, Wanting, Hui, Zhouguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825674/
https://www.ncbi.nlm.nih.gov/pubmed/35154567
http://dx.doi.org/10.1155/2022/5479491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825674/
https://www.ncbi.nlm.nih.gov/pubmed/35154567
http://dx.doi.org/10.1155/2022/5479491

Ejemplares similares